Palisade Bio (PALI) Assets Average (2011 - 2026)
Palisade Bio's (PALI) quarterly Assets Average came in at $133.8 million in Q1 2026, up 1303.56% year-on-year from $9.5 million in Q1 2025, and up 89.4% on a QoQ basis from $70.7 million in Q4 2025.
Palisade Bio (PALI) Assets Average (2011 - 2026) Analysis & Trends
Palisade Bio (PALI) has 16 years of Assets Average data on file, last reported at $133.8 million in Q1 2026.
- On a quarterly basis, Assets Average rose 1303.56% year-over-year to $133.8 million in Q1 2026; TTM through Mar 2026 was $133.8 million, a 1303.56% increase from a year earlier, with the FY2025 full-year figure at $72.6 million, up 482.48% from the prior year.
- Assets Average for Q1 2026 stood at $133.8 million, up from $70.7 million in the prior quarter.
- Over the last five years, Assets Average for PALI reached as high as $133.8 million in Q1 2026 and fell as low as $6.8 million in Q3 2025.
- Historically, Assets Average has averaged $22.8 million across 5 years, with a median of $12.8 million in 2024.
- Across the five-year window, Assets Average slumped 41.79% in 2025 and jumped 1303.56% in 2026, its largest moves.
- Year by year, Assets Average stood at $16.0 million in 2022, then decreased by 2.84% to $15.6 million in 2023, then sank by 35.04% to $10.1 million in 2024, then jumped by 599.04% to $70.7 million in 2025, then soared by 89.4% to $133.8 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $133.8 million in Q1 2026, $70.7 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 133.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.83 Mn |
| Dec 31, 2025 | 70.66 Mn |
| Sep 30, 2025 | 6.82 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 9.54 Mn |
| Dec 31, 2024 | 10.11 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 12.76 Mn |
| Mar 31, 2024 | 13.35 Mn |
| Dec 31, 2023 | 15.56 Mn |
| Sep 30, 2023 | 17.68 Mn |
| Jun 30, 2023 | 16.78 Mn |
| Mar 31, 2023 | 15.51 Mn |
| Dec 31, 2022 | 16.01 Mn |
| Sep 30, 2022 | 12.04 Mn |
| Jun 30, 2022 | 8.08 Mn |
| Mar 31, 2022 | 10.43 Mn |
| Dec 31, 2021 | 14.39 Mn |
| Sep 30, 2021 | 15.61 Mn |
| Jun 30, 2021 | 11.93 Mn |